We report that higher genetically predicted CSF haptoglobin levels are associated with lower risk of catastrophic aSAH, but not associated with risk of aSAH, intracerebral haemorrhage, stroke, nor with imaging markers of brain swelling, microbleeds, or white matter injury. This evidence concerns the gene HP and stroke disorder.